Daher Ayham, Dreher Michael
Department of Pneumology and Intensive Care Medicine, University Hospital Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.
Herz. 2020 Apr;45(2):110-117. doi: 10.1007/s00059-020-04893-4.
Chronic obstructive pulmonary disease (COPD) and coronary artery disease (CAD) not only have smoking as a common risk factor, they also share epidemiological relationships and important mutual effects. There is good evidence to suggest that COPD is highly prevalent but underdiagnosed among CAD patients and vice versa. The symptoms of the two diseases can overlap, making differential diagnosis challenging. This highlights the importance of pulmonary function tests (PFTs) in patients with CAD but also a cardiological assessment in patients with COPD. Chronic obstructive pulmonary disease is a risk factor for the development of CAD independent of other cardiovascular risk factors, and the presence of COPD worsens prognosis in patients with CAD. Mechanisms underlying the associations between COPD and CAD have been less well studied, but inflammation is increasingly being recognized as an important factor linking the two diseases. Other potential contributors include increased oxidative stress, platelet activation, and arterial stiffness. The influence of medications used to treat one condition on the other one needs to be understood and taken into account in patient management. Physicians need to be aware of the important links between COPD and CAD, both of which are commonly encountered in clinical practice. This should help to optimize the management of both conditions to improve patient outcomes.
慢性阻塞性肺疾病(COPD)和冠状动脉疾病(CAD)不仅有吸烟这一共同危险因素,它们还存在流行病学关联以及重要的相互影响。有充分证据表明,COPD在CAD患者中高度流行但诊断不足,反之亦然。这两种疾病的症状可能重叠,使得鉴别诊断具有挑战性。这凸显了肺功能测试(PFT)在CAD患者中的重要性,同时也凸显了对COPD患者进行心脏评估的重要性。慢性阻塞性肺疾病是CAD发生发展的一个危险因素,独立于其他心血管危险因素,且COPD的存在会使CAD患者的预后恶化。COPD与CAD之间关联的潜在机制研究较少,但炎症越来越被认为是连接这两种疾病的一个重要因素。其他潜在因素包括氧化应激增加、血小板活化和动脉僵硬度增加。在患者管理中,需要了解并考虑用于治疗一种疾病的药物对另一种疾病的影响。医生需要意识到COPD和CAD之间的重要联系,这两种疾病在临床实践中都很常见。这有助于优化对这两种疾病的管理,以改善患者的预后。